Literature DB >> 16413342

Association between marijuana use and transitional cell carcinoma.

Julie A Chacko1, Jared G Heiner, Wendy Siu, Marie Macy, Martha K Terris.   

Abstract

OBJECTIVES: Marijuana smoking has been implicated as a causative factor in traditionally tobacco-related tumors of the head and neck and of the lung. When associated with marijuana use, such tumors occur in a much younger patient population than do similar tumors in tobacco smokers. Owing to the large number of young men with a history of marijuana presenting with transitional cell carcinoma to VA facilities, this study was designed to compare the marijuana use among young (aged less than 60 years) transitional cell carcinoma patients with that among age-matched controls.
METHODS: Fifty-two men aged less than 60 years presenting consecutively with transitional cell carcinoma and 104 age-matched controls (defined by having no history of transitional cell carcinoma, hematuria, or irritative voiding symptoms, as well as unremarkable results on urinalysis and urine cytology) completed questionnaires about exposure to various potential carcinogens, including radiation, Agent Orange, smoked or processed meats, dyes, tobacco, and marijuana.
RESULTS: Of the 52 transitional cell carcinoma patients, 46 (88.5%) reported a history of habitual marijuana usage, and 72 (69.2%) of the age-matched controls gave a history of habitual marijuana use. This difference was statistically significant (P = 0.008). In those with transitional cell carcinoma, marijuana use significantly correlated with tumor stage, grade, and number of recurrences.
CONCLUSIONS: Marijuana smoking might increase the risk of transitional cell carcinoma.

Entities:  

Mesh:

Year:  2006        PMID: 16413342     DOI: 10.1016/j.urology.2005.07.005

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  20 in total

Review 1.  Medical consequences of marijuana use: a review of current literature.

Authors:  Adam J Gordon; James W Conley; Joanne M Gordon
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

Review 2.  An epidemiologic review of marijuana and cancer: an update.

Authors:  Yu-Hui Jenny Huang; Zuo-Feng Zhang; Donald P Tashkin; Bingjian Feng; Kurt Straif; Mia Hashibe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01       Impact factor: 4.254

3.  Identifying risk factors for marijuana use among veterans affairs patients.

Authors:  Marina Goldman; Jesse J Suh; Kevin G Lynch; Regina Szucs; Jennifer Ross; Hu Xie; Charles P O'Brien; David W Oslin
Journal:  J Addict Med       Date:  2010-03       Impact factor: 3.702

4.  Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties.

Authors:  Venkatesh L Hegde; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Eur J Immunol       Date:  2010-12       Impact factor: 5.532

5.  Marijuana smoking and the risk of head and neck cancer: pooled analysis in the INHANCE consortium.

Authors:  Julien Berthiller; Yuan-Chin Amy Lee; Paolo Boffetta; Qingyi Wei; Erich M Sturgis; Sander Greenland; Hal Morgenstern; Zuo-Feng Zhang; Philip Lazarus; Joshua Muscat; Chu Chen; Stephen M Schwartz; José Eluf Neto; Victor Wünsch Filho; Sergio Koifman; Maria Paula Curado; Elena Matos; Leticia Fernandez; Ana Menezes; Alexander W Daudt; Gilles Ferro; Paul Brennan; Mia Hashibe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

6.  Protecting against intergenerational problem behavior: mediational effects of prevented marijuana use on second-generation parent-child relationships and child impulsivity.

Authors:  Nathaniel R Riggs; Chih-Ping Chou; Mary Ann Pentz
Journal:  Drug Alcohol Depend       Date:  2008-11-25       Impact factor: 4.492

Review 7.  Urological complications of illicit drug use.

Authors:  Sean C Skeldon; S Larry Goldenberg
Journal:  Nat Rev Urol       Date:  2014-02-18       Impact factor: 14.432

Review 8.  Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?

Authors:  Mahmoud Abu-Amna; Talal Salti; Mona Khoury; Idan Cohen; Gil Bar-Sela
Journal:  Curr Treat Options Oncol       Date:  2021-01-13

9.  Bogarting that joint might decrease oral HPV among cannabis users.

Authors:  S R Zwenger
Journal:  Curr Oncol       Date:  2009-12       Impact factor: 3.677

Review 10.  Use of cannabis in urological cancer patients: A review to evaluate risk for cancer development, therapeutic use, and symptom management.

Authors:  Shipra Taneja; Jen Hoogenes; Marissa Slaven; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.